Inhibition of CX3C receptor 1-mediated autophagy in macrophages alleviates pulmonary fibrosis in hyperoxic lung injury

Yuqing Chen,Hai Zhang,Feng Li,Xiaohui Wang
DOI: https://doi.org/10.1016/j.lfs.2020.118286
IF: 6.78
2020-10-01
Life Sciences
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Aims</h3><p>To investigate the role of CX3CR1 in hyperoxic lung injury induced pulmonary fibrosis.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Materials and methods</h3><p>Hyperoxic lung injured mice were used as the disease model. Pulmonary fibrosis was determined by H&amp;E and Masson's staining. Autophagy was investigated by western blot, immunofluorescence staining, and transmission electron microscopy.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Key findings</h3><p>We observed that increased CX3CR1 expression corresponded with increased pulmonary fibrosis. Additionally, silencing of CX3CR1 significantly alleviated the fibrosis when compared to the control. We observed that exposure of mouse to hyperoxic environment increased macrophage levels along with an increased CD11b expression in the lung tissues. Subsequently, we also observed an increased expression of LC3-II and decreased p62 expression in hyperoxic mice models, suggesting the potential role of hyperoxia induced autophagy. CD11b and LC3/CX3CR1 were expressed and co-localized in a manner indicating CX3CR1 indeed does regulate macrophage autophagy in the hyperoxic lung injury model. We observed a decrease in hyperoxia-associated fibrosis, along with a decrease in autophagy when we used 3-MA (autophagy inhibitor) in our hyperoxic lung injury model. To elucidate the pathway through which CX3CR1 regulated autophagy, we further analyzed the Akt1 pathway. Our experimental results indicated that the Akt1 inhibitor (A-674563) did significantly decrease macrophage autophagy and fibrosis in hyperoxic mice models.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Significance</h3><p>Thus, our data indicates a novel role of CX3CR1 in regulation of macrophage autophagy and promotion of pulmonary fibrosis in hyperoxic lung injured mice.</p>
pharmacology & pharmacy,medicine, research & experimental
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the role and mechanism of CX3C chemokine receptor 1 (CX3CR1) in macrophage autophagy during the pulmonary fibrosis process caused by lung injury in a hyperoxic environment. Specifically, the researchers want to explore the following aspects: 1. **Expression changes of CX3CR1 in hyperoxic lung injury**: The researchers first observed the effect of the hyperoxic environment on the expression of CX3CR1 in mouse lung tissues to determine whether CX3CR1 plays a role in hyperoxia - induced lung injury. 2. **Effect of CX3CR1 over - expression on pulmonary fibrosis**: By constructing a CX3CR1 over - expression mouse model, the researchers evaluated whether CX3CR1 over - expression exacerbates hyperoxia - induced pulmonary fibrosis. 3. **Effect of CX3CR1 knockdown on pulmonary fibrosis**: By constructing a CX3CR1 - knockdown mouse model, the researchers further verified the role of CX3CR1 in hyperoxia - induced pulmonary fibrosis, that is, whether CX3CR1 knockdown can alleviate pulmonary fibrosis. 4. **Role of macrophage autophagy in hyperoxic lung injury**: The researchers explored the changes in macrophage autophagy in a hyperoxic environment by detecting autophagy markers (such as the LC3 - II/I ratio, p62 expression level, etc.), and further verified the role of autophagy in pulmonary fibrosis by using the autophagy inhibitor 3 - methyladenine (3 - MA). 5. **CX3CR1 regulates macrophage autophagy through the Akt1 signaling pathway**: In order to clarify the specific mechanism by which CX3CR1 regulates autophagy, the researchers treated mice with the Akt1 inhibitor A - 674563, observed its effect on autophagy markers and pulmonary fibrosis, and thus revealed the mechanism by which CX3CR1 regulates macrophage autophagy through the Akt1 signaling pathway. In summary, this paper aims to clarify the role of CX3CR1 in hyperoxia - induced lung injury and pulmonary fibrosis and its mechanism through regulating macrophage autophagy by a series of experiments, providing a theoretical basis for further developing new strategies for treating hyperoxic lung injury.